STOCK TITAN

ClearPoint Neuro (CLPT) investors disclose 7.45% beneficial ownership stake

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

ClearPoint Neuro, Inc. shareholders led by Bigger Capital Fund, LP and affiliated entities filed an amended Schedule 13G reporting their beneficial ownership of the company’s common stock. As of August 4, 2026, Bigger Capital beneficially owned 1,405,284 shares of common stock, and its general partner Bigger Capital Fund GP, LLC may be deemed to beneficially own the same amount, representing approximately 4.60% of the class.

District 2 Capital Fund LP beneficially owned 295,196 shares, and related District 2 entities may be deemed to beneficially own that stake, representing 0.96% of outstanding shares. Michael Bigger, through his roles with Bigger GP and District 2 Holdings and his personal and family holdings, may be deemed to beneficially own 2,272,980 shares, or approximately 7.45% of the outstanding common stock, while Patricia Winter holds 167,000 shares, or 0.54%. These percentages are based on 30,504,227 shares outstanding as of July 27, 2026; the filing includes customary disclaimers of beneficial ownership among the reporting persons.

Positive

  • None.

Negative

  • None.
Shares outstanding 30,504,227 shares Common stock outstanding as of July 27, 2026
Bigger Capital beneficial ownership 1,405,284 shares Shares of ClearPoint Neuro common stock beneficially owned by Bigger Capital as of August 4, 2026
Bigger Capital ownership percentage 4.60% Approximate percentage of outstanding common stock beneficially owned
District 2 Capital Fund LP holdings 295,196 shares Shares of common stock beneficially owned as of August 4, 2026
District 2 Capital Fund LP percentage 0.96% Percentage of outstanding common stock beneficially owned
Michael Bigger total beneficial ownership 2,272,980 shares Aggregate shares he may be deemed to beneficially own as of August 4, 2026
Michael Bigger ownership percentage 7.45% Approximate percentage of outstanding common stock beneficially owned
beneficially own regulatory
"As of August 4, 2026, Bigger Capital beneficially owned 1,405,284 shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
dispositive power regulatory
"may be deemed to share voting and dispositive power over the shares"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
voting power regulatory
"may be deemed to share voting and dispositive power over the shares"
Voting power is the ability shareholders have to influence a company's major decisions—like electing the board, approving mergers, or changing corporate rules—based on the voting rights attached to the shares they hold. For investors it matters because greater voting power is like holding more keys to a building: it gives you a stronger say over management choices and the company’s strategy, which can affect future value and risk.
Schedule 13G regulatory
"shareholders ... filed an amended Schedule 13G reporting their beneficial ownership"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
managing member financial
"Michael Bigger, Managing Member of Bigger Capital Fund GP, LLC"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What ownership stakes in ClearPoint Neuro (CLPT) are reported in this Schedule 13G/A?

The filing reports that Bigger Capital beneficially owns 1,405,284 shares (about 4.60%), District 2 Capital Fund LP owns 295,196 shares (about 0.96%), and Michael Bigger may be deemed to beneficially own 2,272,980 shares (about 7.45%).

How many ClearPoint Neuro (CLPT) shares are outstanding for these percentage calculations?

Percentages are based on 30,504,227 shares of ClearPoint Neuro common stock outstanding as of July 27, 2026, as referenced from the issuer’s Form 10-Q filed on August 3, 2026.

What percentage of ClearPoint Neuro (CLPT) does Michael Bigger beneficially own?

As of August 4, 2026, Michael Bigger may be deemed to beneficially own 7.45% of ClearPoint Neuro’s common stock, corresponding to 2,272,980 shares, including shares held through funds, his IRA, and certain family holdings.

What is Patricia Winter’s reported ownership in ClearPoint Neuro (CLPT)?

Patricia Winter holds 167,000 shares of ClearPoint Neuro common stock, representing 0.54% of the outstanding shares, based on 30,504,227 shares outstanding as of July 27, 2026.

Who are the reporting persons in this ClearPoint Neuro (CLPT) Schedule 13G/A filing?

Reporting persons include Bigger Capital Fund, LP, Bigger Capital Fund GP, LLC, District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, District 2 Holdings LLC, Michael Bigger, and Patricia Winter, who collectively report beneficial ownership.

What voting and dispositive powers over ClearPoint Neuro (CLPT) shares are described?

The filing states that Bigger GP and Michael Bigger may share voting and dispositive power over shares held by Bigger Capital, and that District 2, its affiliates, and Michael Bigger may share such powers over District 2 Capital Fund LP’s holdings.





18507C103

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



BIGGER CAPITAL FUND L P
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member of Bigger Capital Fund GP, LLC, its general partner
Date:08/04/2026
Bigger Capital Fund GP, LLC
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:08/04/2026
District 2 Capital Fund LP
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member of District 2 GP LLC, its general partner
Date:08/04/2026
District 2 Capital LP
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:08/04/2026
District 2 GP LLC
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:08/04/2026
District 2 Holdings LLC
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger, Managing Member
Date:08/04/2026
Bigger Michael
Signature:/s/ Michael Bigger
Name/Title:Michael Bigger
Date:08/04/2026
Patricia Winter
Signature:/s/ Patricia Winter
Name/Title:Patricia Winter
Date:08/04/2026